This activity is part of a 14-course series designed to equip licensed practitioners from medical, nursing, and related disciplines with a multidisciplinary approach to managing patients with psoriasis.
12. Safety of Biologics
One-third of adult psoriasis patients develop symptoms starting in childhood. Learn about the diagnostic challenges and management of childhood psoriasis.
After completing this activity, participants will able to:
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
|Name of Faculty||Reported Financial Relationship|
|Jashin Wu, MD||Research Funding: AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Regeneron|
This activity is jointly provided by SynAptiv and Dermeda
Questions about CE accreditation or CE certificates related to this course, please contact us via email at email@example.com.
Copyright © 2018 Dermveda. All rights reserved. This material may not be reproduced, displayed, modified or distributed without the express prior written permission of the copyright holder.